Clinical Trials
AI in Alzheimer Drug Development to Enhances Clinical Trials
Scientists applied artificial intelligence (AI) to reanalyse a clinical trial for AI in Alzheimer Drug Development, identifying a group of patients who responded to medical treatment. The study shows that AI can help design future clinical trials to be...
Clinical Trials
Nipah Virus Vaccines Enter Clinical Trials in Bangladesh
Two Vaccines against the Nipah virus, a deadly bat-borne virus, are scheduled to begin human clinical trials in Bangladesh, while intriguing medication candidates have demonstrated the ability to treat and prevent infection.
While Nipah case numbers remain low, climate change...
News
LL-37: Immunity, Microbial Defense, and Regenerative Research
LL-37, a 37-amino acid peptide derived from the cathelicidin antimicrobial peptide precursor hCAP18, has emerged as a molecule of considerable research interest. Encoded by the CAMP gene, LL-37 is the only known cathelicidin and is expressed in a variety...
Business & Industry
Sino BioPharm to Acquire LaNova Medicines for $950.9 M Deal
LaNova Medicines, which happens to be a cancer drugmaker that previously licensed medicines to AstraZeneca as well as Merck & Co., has gone on to agree to get acquired by Sino BioPharmaceuticals in a deal worth almost $951 million.
In...
News
Rheumatoid Arthritis Treatment with Genetic Link Adds Hope
Researchers at the University of Edinburgh have gone on to identify a genetic link that could revolutionize rheumatoid arthritis treatment. This discovery now opens the doors to innovative drug development as well as better patient outcomes, potentially elevating the...
News
Sleep Lean Reviews – Is It Effective for Weight Loss?
Sleep Lean is a dietary supplement formulated for people who want to enhance deep sleep and support healthy weight loss. Designed as a dual-action formula, Sleep Lean helps user’s burn fat and rest well by targeting both stress levels...
Clinical Trials
CDSCO Moves to Online Submission for CGTP Trial Applications
As part of its continued efforts to streamline operations through digitisation, the Central Drugs Standard Control Organisation (CDSCO) has transitioned from offline to online acceptance of clinical trial applications for cell and gene therapies products (CGTP).
The agency has also...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















